Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
12/2005
12/01/2005US20050267047 Diarylalkanes as potent inhibitors of binuclear enzymes
12/01/2005DE102004022397A1 Chirale C2-symmetrische Biphenyle, deren Herstellung sowie Metallkomplexe enthaltend diese Liganden und deren Verwendung als Katalysatoren in chirogenen Synthesen Chiral C2-symmetric biphenyls, their preparation and metal complexes containing these ligands and their use as catalysts in synthesis chirogenic
11/2005
11/24/2005WO2005111134A2 Method of nucleating a polyolefin composition with acetal-based compounds
11/17/2005WO2005108479A2 Acetal-based compositions
11/17/2005US20050256183 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
11/16/2005EP1595887A1 Chiral C2-symmetric biphenyls, preparation thereof as well as metal complexes containing these ligands and the use as catalysts in chirogene synthesis
11/16/2005EP1594855A2 Signalling compounds for use in methods of detecting hydrogen peroxide
11/10/2005US20050250951 Chiral C2-symmetric biphenyls, their preparation and also metal complexes in which these ligands are present and their use as catalysts in chirogenic syntheses
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
10/2005
10/27/2005WO2005100333A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005US20050240034 Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
10/27/2005US20050239928 Dibenzylidenesorbitol derivatives made by condensation, acetalization, and cyclization of benzaldehyde derivative and mono-, di-, or tri-acetal substituted alditol; nucleating, gelling, or clarifying agents; thickeners; plastic and/or polypropylene additive
10/27/2005US20050239926 Method of nucleating a polyolefin composition with acetal-based compounds
10/26/2005CN1688576A Thiophene compounds
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/13/2005US20050227908 1,5-dioxa-3-methyl-16-cyclohexadecanone; original odor characteristics, diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery.
10/12/2005CN1680391A Preparation of bromo-dihydroartemisine
10/12/2005CN1680390A Halogenated dihydroartemisine, preparation and use thereof
10/12/2005CN1680389A Bromo-dihydroartemisine
10/12/2005CN1680388A Extraction of artemisine
10/06/2005WO2005092328A1 Fxr activation compound
10/06/2005WO2005049562A3 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
09/2005
09/28/2005CN1220690C 5-benzamido-1, 3-dioxide cyclo group compound and preparation process thereof, and use in preparing protein kinase C inhibito medicine
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949291 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005044130A9 Pdk-1/akt signaling inhibitors
09/07/2005CN1217885C Method for producing ketal and/or acetal
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
08/2005
08/25/2005WO2004074810A3 Signalling compounds for use in methods of detecting hydrogen peroxide
08/18/2005US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/17/2005CN1215065C Method for synthesizing aromatic cyclic oligomer
08/10/2005EP1560630A2 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
07/2005
07/28/2005US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
07/20/2005EP1554263A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
07/19/2005US6919463 A boronate derivatives, reacting with a source of hydrogen peroxide to produce a colorimetric, fluorescent, chemiluminescent or bioluminescent product, detecting enzymes which generate hydrogen peroxide, quantitative analysis
07/14/2005WO2005062811A2 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
07/14/2005US20050153389 Method for the production of bioactive substances from the novel actinomycete taxon MAR2 ("Marinophilus")
07/14/2005US20050153365 Capable of inducing chemiluminescence; substrates for immunoassay; stability; low background for measurement to present high sensitivity
07/12/2005US6916940 Oxidation, fluorination, desulfurization
07/12/2005US6916802 Synthase inhibitors for lowering glycosphingolipid levels; anticancer agents; for treatment of Gaucher's disease
07/07/2005WO2005061459A1 Biaryl sulfonamides and methods for using same
07/07/2005WO2005060456A2 Method for treating adamts-5-associate disease
07/07/2005US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
07/07/2005CA2548513A1 Biaryl sulfonamides and methods for using same
07/07/2005CA2547575A1 Method for treating adamts-5-associated disease
07/05/2005US6913897 Comprises dioxetane compound and phosphatases
06/2005
06/30/2005US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
06/29/2005EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/22/2005CN1207268C Novel derivatives of 3-3-diphenylpropylamines
06/21/2005US6908935 Calcium receptor modulating agents
06/16/2005US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/15/2005CN1626529A Esters compound of dibenzanthracene-1,3-dioxa-cyclooctane-2-amine carboxylic acid of possessing weeding activity
06/15/2005CN1626528A Compound of dibenzanthracene-1,3-dioxa-cyclooctane-2-amide class of possessing weeding activity
06/08/2005CN1623988A Biaryl sulfonamides and methods for using same
06/02/2005WO2005049562A2 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
06/01/2005EP1534660A1 Ketocampholenic acid derivatives and their use in fragrance and flavor applications
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/2005
05/26/2005US20050113374 Benzodioxepine derivatives
05/25/2005EP1341742B1 Method for producing compounds having a cf2o bridge
05/19/2005WO2005044814A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
05/19/2005WO2005044130A1 Pdk-1/akt signaling inhibitors
05/19/2005CA2551056A1 Benzo[b][1,4]dioxepine derivatives
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/10/2005US6890949 Amino ceramide-like compounds and therapeutic methods of use
05/10/2005US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation
05/06/2005WO2005039500A2 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”)
05/06/2005CA2546737A1 Method for the production of bioactive substances from the novel actinomycete taxon mar2 ("marinophilus")
04/2005
04/07/2005WO2005030749A1 Calcilytic compounds
04/07/2005WO2005030684A1 PROCESS FOR PRODUCING α-METHYLSTYRENE
03/2005
03/24/2005WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
03/24/2005WO2005025490A2 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140
03/23/2005CN1597679A Preparation of bibenzo-1, 5- bioxa -cyclo octane -2- acetone oxime carboxylate herbicide
03/16/2005EP1420779A4 Process for isolating phenolic compounds
03/03/2005US20050049235 Amino ceramide-like compounds and therapeutic methods of use
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005CN1191263C 3-deoxy-desmycosin derivatives and process for their preparation
02/2005
02/24/2005US20050043541 five-coordinate metal complex, a salt, a solvate or an enantiomer comprising a carbene ligand, a multidentate ligand and a constraint steric hindrance ligand having a pKa of >15; high activity at moderate temperatures; narrow molecular weight distribution addition polymers; unsaturation reactions
02/24/2005US20050043396 Acetalization of N-benzoylamino glycol with 1,1,3,3-teramethoxy glycol; protein kinase C inhibitors
02/23/2005CN1585742A Aryl aniline beta-2 adrenergic receptor agonists
02/17/2005WO2005014569A1 1,2,4,-trioxepanes as precursors for lactones
02/16/2005CN1189464C 1,2-substituted 2,3-dihydro-1H-5, 9-dioxide heterocyclic heptyl and [f] indine-8-ketone and 7-substituted benzo [b][1,4] dioxide heterocyclic geptyl-1-ketone
02/09/2005EP0983999B1 Process for producing amide derivatives and intermediates
01/2005
01/27/2005WO2005007151A1 Chromatosis remedies
01/27/2005US20050020661 Antidiabetic agents
01/27/2005CA2532313A1 Medicament for treatment of dermal pigmentation
01/19/2005CN1566055A Optically pure bi-substituted binaphthalene phenol and synthetic method thereof
01/18/2005US6844462 Biphenydiols
01/18/2005US6844453 1,2-Dioxetane derivatives and reagents employing them
01/12/2005EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/2004
12/30/2004US20040266701 Novel polyol macrolide antitumor-antibiotics from the novel actinomycete strain CNQ140
12/23/2004US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/22/2004EP1487816A1 Ether lactone
12/22/2004CN1556699A Process for isolating phenolic compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 21